Related Experiment Video

Updated: Aug 26, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Cerebral oedema in childhood diabetic ketoacidosis: is treatment a factor?

T B Brown1

  • 1UCLA Emergency Medicine Center, 23630 Latana Court, Valencia, CA 91355, USA. tbransonbrown@attbi.com

Emergency Medicine Journal : EMJ
|February 28, 2004
PubMed

Insights

Cerebral edema (CO), a severe complication of diabetic ketoacidosis (DKA) in children, remains poorly understood. This review examines if DKA treatment contributes to CO development, a persistent mystery in pediatric care.

Area of Science:

  • Pediatric Endocrinology
  • Neurology
  • Metabolic Disorders

Background:

  • Cerebral edema (CO) is a life-threatening complication of diabetic ketoacidosis (DKA) in children.
  • Despite advances in DKA management, CO mortality rates have remained stagnant for decades.
  • CO complicates approximately 1% of pediatric DKA cases, with a 20-50% fatality rate.

Purpose of the Study:

  • To review existing literature addressing the potential causal link between DKA treatment and CO development in children.
  • To explore the ongoing debate regarding the etiology of CO in pediatric DKA.

Main Methods:

  • Comprehensive literature review of studies investigating cerebral edema in pediatric diabetic ketoacidosis.
  • Analysis of research supporting and refuting the hypothesis that DKA treatment triggers CO.

Main Results:

  • Conflicting evidence exists regarding the role of DKA treatment in the pathogenesis of CO.
  • The exact cause of CO in childhood DKA remains elusive despite extensive research.
  • The relationship between DKA management strategies and CO incidence is a subject of ongoing scientific debate.

Conclusions:

  • The etiology of cerebral edema in pediatric diabetic ketoacidosis is complex and not fully elucidated.
  • Further research is required to definitively determine if DKA treatment contributes to CO development.
  • Understanding the triggers for CO is critical for improving outcomes in pediatric DKA patients.

More Related Videos

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...